T. Rowe Price Associates »

Neuropace shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $228k 17k 13.17
2025-12-31 $230k 15k 15.50
2025-09-30 $125k 12k 10.37
2025-06-30 $135k 12k 11.20

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
Geode Capital Management
FMR
State Street Corporation
Silvercrest Asset Management Group
Northern Trust

View all funds holding Neuropace